GW Pharmaceuticals Releases a Q4 Revenue Beat, but Will the Rapid Growth Continue? Scott Willis·January 13, 2020GW Pharmaceuticals' (NASDAQ: GWPH) 7% revenue beat was cheered by the markets, but with revenue growth slowing can...Marijuana News·0 Comments·
Britain’s First Cannabis-Based Medicine Will Be Available in January Martin Green·December 23, 2019Epidyolex will be available for British epilepsy sufferers from Jan. 6 after the government fast-tracked it into the...Marijuana Politics·4 Comments·
